Leading in minimally invasive therapies for arterial disease, venous disease and cancer
Delivering Meaningful Innovation
Advancing the Treatment of Arterial Disease. Over 200M patients around the world suffer from Peripheral Arterial Disease (PAD) with less than 1% receiving an intervention. We’ve built a strong portfolio of products to serve this market and are uniquely positioned to provide physicians and hospital systems with a full tool box of solutions to treat patients.
Venous Therapies. Our venous portfolio offers a category-leading breadth of venous technologies including: venous stents, endovenous chemical ablation, ultrasound assisted clot dissolution devices, mechanical thrombectomy and imaging catheters.
Tumor-Tackling Technologies. Our interventional oncology portfolio includes embolization technologies, TheraSphere™ Y90 transarterial radioembolization treatment, and ablation technologies, all designed to prevent growth and cause tumor necrosis.
Conditions We Treat
- Peripheral Artery Disease
- Deep Vein Thrombosis (DVT)
- Critical Limb Ischemia
- Superficial Venous Disease
- Pulmonary Embolism (PE)
- Liver Cancer
- Kidney Cancer
Products and Solutions We Offer
- Peripheral Balloons and Stents
- Drug-Eluting Technologies
- Crossing Technology
- Guidewires & Accessories
- Venous Obstruction
- Clot Management
- Imaging
- Venous Insufficiency
- Embolization
- Cancer Therapies
- Tumor Ablation & Treatments
- Access Delivery
Product spotlights
Sources
1. Fowkes, F, et. al., The Lancet, Volume 382, Issue 9901, 1329-1340
2. Gerotziafas GT, et. al., Curr Opin Pulm Med. 2004; 10:356-365; Cohen AT, et.al., Thromb Haemost. 2007 Oct;98(4):756-64
3. International Association of Cancer Registries; GLOBOCAN Database: http://gco.iarc.fr/